Reyes Financial Architecture Inc. Purchases New Stake in ICU Medical, Inc. $ICUI

Key Points

• Reyes Financial Architecture Inc. purchased 27,035 ICU Medical shares worth approximately $4.34 million, making ICUI its sixth-largest holding and representing about 2.7% of its portfolio.
• Institutional investors own 96.1% of ICU Medical, while insiders have sold 21,830 shares worth roughly $3.9 million over the past 90 days.
• Analysts maintain a “Moderate Buy” consensus with a $192.80 price target. ICU Medical recently beat quarterly earnings and revenue estimates, reporting $2.37 EPS and $547.88 million in revenue.

Reyes Financial Architecture Inc. purchased a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 27,035 shares of the medical instruments supplier's stock, valued at approximately $4,339,000. ICU Medical accounts for about 2.7% of Reyes Financial Architecture Inc.'s holdings, making the stock its 6th largest holding. Reyes Financial Architecture Inc. owned approximately 0.11% of ICU Medical at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ICUI. Allworth Financial LP purchased a new stake in ICU Medical during the second quarter worth approximately $26,000. Versant Capital Management Inc raised its stake in shares of ICU Medical by 26.2% in the 3rd quarter. Versant Capital Management Inc now owns 313 shares of the medical instruments supplier's stock valued at $50,000 after acquiring an additional 65 shares during the period. Hilton Head Capital Partners LLC raised its stake in shares of ICU Medical by 52.0% in the 1st quarter. Hilton Head Capital Partners LLC now owns 336 shares of the medical instruments supplier's stock valued at $43,000 after acquiring an additional 115 shares during the period. Public Employees Retirement System of Ohio acquired a new position in shares of ICU Medical during the 2nd quarter valued at $51,000. Finally, Rockefeller Capital Management L.P. lifted its holdings in shares of ICU Medical by 21.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier's stock valued at $117,000 after acquiring an additional 146 shares in the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, COO Christian Voigtlander sold 8,929 shares of the business's stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $182.93, for a total value of $1,633,381.97. Following the transaction, the chief operating officer owned 37,377 shares in the company, valued at $6,837,374.61. The trade was a 19.28% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Elisha W. Finney sold 378 shares of the company's stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $182.48, for a total transaction of $68,977.44. Following the completion of the transaction, the director directly owned 4,871 shares of the company's stock, valued at approximately $888,860.08. The trade was a 7.20% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 21,830 shares of company stock worth $3,905,003. 2.10% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on ICUI. Zacks Research cut shares of ICU Medical from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 28th. KeyCorp increased their price target on ICU Medical from $164.00 to $182.00 and gave the company an "overweight" rating in a report on Tuesday, July 21st. Piper Sandler raised their price objective on ICU Medical from $163.00 to $195.00 and gave the company an "overweight" rating in a research report on Friday, August 7th. Needham & Company LLC boosted their price objective on ICU Medical from $165.00 to $187.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Finally, Raymond James Financial restated a "strong-buy" rating and set a $200.00 price objective on shares of ICU Medical in a research note on Friday, August 7th. Two research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $192.80.

ICU Medical Stock Up 4.7%

Shares of NASDAQ:ICUI opened at $168.33 on Friday. The company has a quick ratio of 1.21, a current ratio of 2.43 and a debt-to-equity ratio of 0.56. ICU Medical, Inc. has a 52-week low of $113.37 and a 52-week high of $192.85. The company has a 50 day moving average of $166.06 and a two-hundred day moving average of $150.73. The company has a market capitalization of $4.21 billion, a price-to-earnings ratio of 142.65, a price-to-earnings-growth ratio of 2.02 and a beta of 0.86.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $2.37 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.91 by $0.46. ICU Medical had a net margin of 1.39% and a return on equity of 7.91%. The company had revenue of $547.88 million for the quarter, compared to analyst estimates of $533.44 million. During the same quarter last year, the firm posted $2.10 earnings per share. The business's quarterly revenue was up .5% on a year-over-year basis. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. As a group, analysts forecast that ICU Medical, Inc. will post 7.22 earnings per share for the current fiscal year.

ICU Medical Company Profile

ICU Medical, Inc develops, manufactures and sells medical devices and systems used in infusion therapy, critical care and oncology. Its products are designed to support the delivery of fluids, medications and nutrition while helping healthcare providers improve safety and efficiency in clinical settings.

The company's portfolio includes infusion pumps, dedicated and non-dedicated administration sets, needle-free connectors, intravenous solutions and other infusion consumables. ICU Medical also offers products for critical care monitoring and vascular access, as well as closed-system transfer devices and related technologies used in the preparation and administration of hazardous drugs.

Founded in 1984, ICU Medical has expanded through internal development and acquisitions, including the acquisition of Hospira's infusion systems business in 2017 and Smiths Medical in 2022.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.